(Q40825168)

24 September 2017

1 reference

title

Immunotherapy of endotoxemia and septicemia (English)

1 reference

24 September 2017

0 references

1 reference

1 reference

Baumgartner JD

1

1 reference

24 September 2017

Glauser MP

series ordinal

2

1 reference

24 September 2017

publication date

1 April 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

187

1 reference

24 September 2017

issue

3-5

1 reference

24 September 2017

page(s)

464-477

1 reference

Heterogeneity of the Haemagglutinin Responses to Salmonella minnesota R-Antigens in Rabbits

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Antibodies to Core Lipopolysaccharide Determinants: Absence of Cross-reactivity with Heterologous Lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Anti-endotoxin monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Protective antibody to endotoxin core: the emperor's new clothes?

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Resistance to meningococcemia apparently conferred by anti-H.8 monoclonal antibody is due to contaminating endotoxin and not to specific immunoprotection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Implications of endotoxin contamination in the evaluation of antibodies to lipopolysaccharides in a murine model of gram-negative sepsis.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Failure of antisera to J5 and R595 rough mutants to reduce endotoxemic lethality.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Experimental Gram-Negative Bacterial Sepsis: Reevaluation of the Ability of Rough Mutant Antisera to Protect Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Experimental gram-negative bacterial sepsis: prevention of mortality not preventable by antibiotics alone

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Experimental Gram-negative bacterial sepsis: optimal methylprednisolone requirements for prevention of mortality not preventable by antibiotics alone

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Neutralization of meningococcal endotoxin by antibody to core glycolipid

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Treatment of severe infectious purpura in children with human plasma from donors immunized with Escherichia coli J5: a prospective double-blind study. J5 study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Prevention of gram-negative shock and death in surgical patients by antibody to endotoxin core glycolipid.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Treatment of Gram-Negative Septic Shock with Human IgG Antibody to Escherichia coli J5: A Prospective, Double-Blind, Randomized Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Effects of IgM and IgG Antibody in Patients with Bacteremia Due to Gram-Negative Bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Antibodies to Lipopolysaccharides after Immunization of Humans with the Rough Mutant Escherichia coli J5

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Type-Specific and Cross-Reactive Antibodies in Gram-Negative Bacteremia

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Prophylactic intravenous administration of standard immune globulin as compared with core-lipopolysaccharide immune globulin in patients at high risk of postsurgical infection

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Protection Against Gram-Negative Infections with Antiserum to Lipid A from Salmonella minnesota R595

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Effect of active and passive immunizations with lipid A and salmonella minnesota Re 595 on gram-negative infections in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Lipid A and Anti-Lipid A

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Characterization of murine monoclonal antibodies to Escherichia coli J5

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Specificity and cross-reactivity of monoclonal antibodies reactive with the core and lipid A regions of bacterial lipopolysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

Production and characterisation of mouse monoclonal antibodies reacting with the lipopolysaccharide core region of gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0171-2985%2811%2980357-8

7 January 2021

10.1016/S0171-2985(11)80357-8

Identifiers

DOI

0 references

1 reference